Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation

Experimental Hematology

Volumn 36, Issue 12, 2008, Pages

  Takahashi, Naoyuki ^a   Sato, Noriharu ^a,b   Takahashi, Satoshi ^c   Tojo, Arinobu ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Sato Clinic of Internal Medicine   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD161 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; MELPHALAN; METHOTREXATE; PREDNISOLONE; RANTES; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE EXACERBATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; MALE; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UNINDEXED SEQUENCE; WHOLE BODY RADIATION;

EID: 55549091043     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.07.007     Document Type: Article

References (47)

1. Morris E.S., and Hill G.R. Advances in the understanding of acute graft-versus-host disease. Br J Haematol 137 (2007) 3-19
2. Ichiba T., Teshima T., Kuick R., et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102 (2003) 763-771
3. Sugerman P.B., Faber S.B., Willis L.M., et al. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol 164 (2004) 2189-2202
4. Zhou L., Askew D., Wu C., and Gilliam A.C. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 127 (2007) 281-292
5. Takahashi S. Leukemia: cord blood for allogeneic stem cell transplantation. Curr Opin Oncol 19 (2007) 667-672
6. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109 (2007) 1322-1330
7. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
8. Gentleman R.C., Carey V.J., Bates D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5 (2004) R80
9. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
10. Lee E.G., Boone D.L., Chai S., et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289 (2000) 2350-2354
11. Nahta R., Yuan L.X., Fiterman D.J., et al. B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells. Mol Cancer Ther 5 (2006) 1593-1601
12. Busson M., Carazo A., Seyer P., et al. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24 (2005) 1698-1710
13. Jaksch M., and Mattsson J. The pathophysiology of acute graft-versus-host disease. Scand J Immunol 61 (2005) 398-409
14. Kuo C.T., Veselits M.L., and Leiden J.M. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science 277 (1997) 1986-1990
15. Buckley A.F., Kuo C.T., and Leiden J.M. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol 2 (2001) 698-704
16. Das H., Kumar A., Lin Z., et al. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103 (2006) 6653-6658
17. Barjaktarević I., Rahman A., Radoja S., et al. Inhibitory role of IFN-gamma-inducible lysosomal thiol reductase in T cell activation. J Immunol 177 (2006) 4369-4375
18. Jaksch M., Remberger M., and Mattsson J. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 280-287
19. Wysocki C.A., Panoskaltsis-Mortari A., Blazar B.R., and Serody J.S. Leukocyte migration and graft-versus-host disease. Blood 105 (2005) 4191-4199
20. Lee A.H., Hong J.H., and Seo Y.S. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 350 (2000) 131-138
21. + T lymphocytes during primary stimulation. Blood 102 (2003) 4608-4617
22. Makino Y., Cook D.N., Smithies O., et al. Impaired T cell function in RANTES-deficient mice. Clin Immunol 102 (2002) 302-309
23. Jiang H., Van De Ven C., Satwani P., Baxi L.V., and Cairo M.S. Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood. J Immunol 172 (2004) 5870-5879
24. Takahashi T., Dejbakhsh-Jones S., and Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176 (2006) 211-216
25. + T lymphocytes. Immunol Lett. 106 (2006) 48-56
26. + T cells with a potent CD160-mediated cytolytic effector function. Eur J Immunol 36 (2006) 2359-2366
27. Szabolcs P., Park K.D., Reese M., Marti L., Broadwater G., and Kurtzberg J. Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 31 (2003) 708-714
28. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
29. SenBanerjee S., Lin Z., Atkins G.B., et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199 (2004) 1305-1315
30. Sen-Banerjee S., Mir S., Lin Z., et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112 (2005) 720-726
31. Zeiser R., Youssef S., Baker J., Kambham N., Steinman L., and Negrin R.S. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Blood 110 (2007) 4588-4598
32. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 (1998) 1001-1005
33. Carrick D.M., Lai W.S., and Blackshear P.J. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res Ther 6 (2004) 248-264
34. Sugihara M., Tsutsumi A., Suzuki E., et al. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis Rheum 56 (2007) 2160-2169
35. Fabris M., Tolusso B., Di Poi E., et al. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression. J Rheumatol 32 (2005) 998-1005
36. Feinberg M.W., Wara A.K., Cao Z., et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26 (2007) 4138-4148
37. Feinberg M.W., Cao Z., Wara A.K., Lebedeva M.A., Senbanerjee S., and Jain M.K. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem 280 (2005) 38247-38258
38. Smyth M.J., Cretney E., Takeda K., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 193 (2001) 661-670
39. Schmaltz C., Alpdogan O., Kappel B.J., et al. T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med 8 (2002) 1433-1437
40. Nomura S., Ishii K., Inami N., et al. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transpl Immunol 18 (2007) 115-121
41. Lünemann J.D., Waiczies S., Ehrlich S., et al. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J Immunol 168 (2002) 4881-4888
42. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 (2004) 2840-2848
43. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., and Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21 (2004) 589-601
44. + T cells by streptococcal M protein. J Immunol 175 (2005) 677-684
45. + cytotoxic regulatory T cells. Blood 107 (2006) 1031-1038
46. Gerosa F., Nisii C., Righetti S., et al. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 92 (1999) 224-234
47. MacDonald A.J., Duffy M., Brady M.T., et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 185 (2002) 720-727